Zentalis Pharmaceuticals
ZNTL
$11.06
Share price
0.68%
Change (1 day)
-49.80%
Change (1 year)
Categories
Zentalis Pharmaceuticals (ZNTL) - Total assets
Total assets on the balance sheet as of December 2023 : $0.55 B
According to Zentalis Pharmaceuticals's latest financial reports the company's total assets are $0.55 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Zentalis Pharmaceuticals - Total assets on balance sheet (from 2019 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.55 B | 2.3% |
| 2022-12-31 | $0.53 B | 18.66% |
| 2021-12-31 | $0.45 B | 24.33% |
| 2020-12-31 | $0.36 B | 317.87% |
| 2019-12-31 | $87.48 M | 113.38% |
| 2018-12-31 | $40.99 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $2.01 B | 264.64% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $22.68 M | -95.89% | 🇺🇸 USA |